Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
Chinese online pioneer. Tokyo-based patent rights company BWB Inc. filed for an injunction against Alibaba’s overseas transactions at the Seoul Central District Court on Friday. BWB, which owns
Grabinski putting both opponents under intense scrutiny. While the outcome remains completely open, their conduct of the negotiations will have an impact on future UPC proceedings. JUVE Patent reports
Solar manufacturer Maxeon Solar Technologies has said that it is issuing a number of patent infringement investigations in the US pertaining to tunnel oxide passivated contact (TOPCon) solar cell
patent in 2020. In spring 2021, the Indian medical device manufacturer Meril, its German subsidiary and the Danish company Mermaid Medical filed an opposition against the grant. In a first-instance
Patent Court Agreement (“UPCA”) provides for the creation of a patent mediation and arbitration centre (Centre) seated in Ljubljana and Lisbon. Although the stated objective is to give the Centre a key
Motive Technologies Inc. in a Dec. 6 legal filing attacked the legal standing of a technology patent infringement lawsuit filed against it by Omnitracs that alleges Motive for years copied Omnitracs
Plexxikon, a subsidiary of Daiichi Sankyo, and Novartis have settled a patent infringement suit against over the sale of Novartis’ cancer drug Tafinlar in the U.S. Under the settlement announced
Dec 12 (Reuters) - A federal judge in Virginia has rejected cybersecurity company Centripetal Networks' patent infringement claims against Cisco Systems (CSCO.O) in a multi-billion-dollar fight over
of in favor of Acadia’s ‘721 formulation patent. The favorable ruling protects the two marketed forms of Nuplazid. The 10 mg tablet will be protected until 2037 and the 34 mg capsule will be protected
the Patent Law of the People's Republic of China(Decision)”. The amended rules, which will come into force on January 20, 2024, mainly cover the following aspects: improving the patent application
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
